Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-11-22 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2020年限制性股票激励计划第一个归属期归属条件成就的公告
Remuneration Information Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the achievement of vesting conditions for the first vesting period of its 2020 restricted stock incentive plan. It details the number of shares vested, the conditions met, approvals by the board and supervisory committee, legal opinions, and the impact on financials and share capital. The content focuses on stock-based compensation and the vesting of restricted shares to employees and management. This type of document is related to executive and employee remuneration and stock incentive plans rather than a full annual report, earnings release, or management discussion. It is not a proxy solicitation or voting result announcement. The document is a formal disclosure about the stock incentive plan's vesting status and related approvals, which fits best under Remuneration Information (DEF 14A) category, as it details compensation-related stock awards and their vesting.
2021-11-22 Chinese
独立董事关于第五届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several board meeting agenda items, including stock incentive plans, amendments to the company charter, and authorization for management to invest idle funds. It references compliance with laws and company regulations and is signed by independent directors. The content is related to board/management information and decisions rather than a full report or announcement of voting results. The document length is short (1754 characters), and it is not a report publication announcement or regulatory filing. Therefore, it fits best under Board/Management Information (MANG).
2021-11-22 Chinese
第五届监事会第十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding approval of stock incentive plan matters, including the vesting of restricted stock and cancellation of some unvested restricted stock. It includes voting results and references to related announcements filed elsewhere. The document is short (1266 characters) and primarily reports on board meeting decisions rather than detailed financial data or full reports. It does not contain financial statements or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2021-11-22 Chinese
监事会关于2020年限制性股票激励计划第一个归属期归属名单的核查意见
Regulatory Filings Classification · 90% confidence The document is an official announcement from the Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding the verification opinion on the first vesting period list of the 2020 restricted stock incentive plan. It references compliance with company law, securities law, stock exchange listing rules, and internal company regulations. The content focuses on the approval and verification of stock incentive recipients and their qualifications. This type of document is related to director or management share dealings or stock incentive plans but is not a direct report of personal share transactions by directors (which would be DIRS). Instead, it is an official announcement about the stock incentive plan and its vesting verification, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like DIRS or SHA (share issue/capital change). The document is short and formal, without financial statements or detailed financial data, so it is not an Annual Report or Interim Report. Therefore, the best classification is Regulatory Filings (RNS).
2021-11-22 Chinese
关于作废部分已授予尚未归属的第二类限制性股票的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the cancellation of part of the unvested restricted shares under the 2020 restricted stock incentive plan. It details board and supervisory committee meeting approvals, legal opinions, and the impact of the cancellation on the company. The content focuses on corporate governance and management decisions related to stock incentives, not on financial results or earnings. It is not a full financial report, earnings release, or audit report. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement about management decisions on stock incentives, which fits best under Board/Management Information (MANG). The document length is under 5,000 characters and contains detailed information about board resolutions and management decisions, not just a brief notice or report publication announcement. Therefore, the classification is MANG with high confidence.
2021-11-22 Chinese
第五届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the 5th Board of Directors of Guangzhou Yangpu Medical Technology Co., Ltd. It includes multiple board decisions such as approval of stock incentive plans, amendments to the company charter, authorization of management for investment activities, and remuneration management methods. It also mentions voting results and the convening of a shareholders' meeting. The content focuses on board-level decisions and management matters rather than full financial statements or earnings data. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a simple announcement of voting results but a comprehensive board meeting resolution report. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3761 characters, which is sufficient for detailed board resolutions but not a full financial report.
2021-11-22 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.